Protalix BioTherapeutics, a biopharmaceutical company specializing in rare disease treatments, will release its financial results for Q2 2026 on August 12. The company will also provide a business update and discuss recent corporate and regulatory developments during a conference call and webcast at 8:00 a.m. EDT. Protalix is known for its innovative plant cell-based protein production system and has partnerships with Pfizer and Chiesi for its enzyme replacement therapies. Investors can access the live call via phone or webcast, with a replay available for two weeks afterward.
Zcash (ZEC), a privacy-focused cryptocurrency, surged to $1,521, marking a 2,800% gain over the past year. Grayscale announced a 3-for-1 forward stock split for its Zcash ETF (ZCSH), effective September 30, to lower the share price and increase liqui...
Gold and silver prices fell last week due to the U.S. Federal Reserve's rate hike, which boosted the U.S. dollar and pressured metals priced in dollars. However, easing oil prices from restored Gulf exports have softened inflation fears, supporting p...
Bitcoin's market capitalization has risen to $1.615 trillion, surpassing Tesla's $1.438 trillion and Samsung's $1.237 trillion, placing it 13th among global assets. This follows Bitcoin's price peak at $81,914 on Saturday after four consecutive days ...
XRP is testing the crucial $1.50 resistance level that has capped its price for about 230 days. If XRP manages to turn this resistance into support, it could trigger a strong rally toward $1.80 or higher. This level has repeatedly stopped XRP's advan...
Bitcoin ended the week of September 20, 2026, at $81,159, closing above its 50-week moving average of about $78,788 for the first time since November 2025. This breaks a 45-week streak below this key technical level, sparked by a 6% surge on Septembe...
